Fluorescence microscopy and the NO-sensitive indicator 4,5-diaminofluorescein were used to determine the effects of acetylcholine (ACh) on intracellular NO (NO i ) in cat atrial myocytes. Field stimulation (1 Hz) of cells or exposure of quiescent cells to ACh (1 to 10 mol/L) had no effect on NO i . However, in field-stimulated cells, ACh exposure increased NO i , and ACh withdrawal elicited an additional, prominent increase in NO i production. During ACh exposure, addition of 1 mol/L atropine increased NO i production similar to ACh withdrawal. ACh-induced increases in NO i were reduced by prior exposure to 1 mmol/L extracellular Ca 2ϩ ([Ca 2ϩ ] o ) and prevented by 0.5 mmol/L [Ca 2ϩ ] o , 1 mol/L verapamil, 1 mol/L atropine, 10 mol/L L-N 5 -(1-iminoethyl)ornithine, 10 mol/L W-7, or incubating cells in pertussis toxin or 10 mol/L LY294002 (inhibits phosphatidylinositol 3-kinase). Switching to 0.5 mmol/L [Ca 2ϩ ] o during ACh withdrawal prevented the additional increase in NO i . ACh exposure increased phosphorylation (Ser 473 ) of protein kinase B (Akt), and this effect was blocked by LY294002 and unaffected in low (0.5 mmol/L) [Ca 2ϩ ] o . Confocal microscopy revealed that ACh exposure increased NO i at local subsarcolemmal sites, and ACh withdrawal additionally increased NO i by recruiting additional subsarcolemmal release sites. Disruption of caveolae by 2 mmol/L methyl-␤cyclodextrin abolished ACh-induced NO i production. We conclude that in cat atrial myocytes, ACh stimulates NO i release from local subsarcolemmal sites. ACh-induced increases in NO i requires both muscarinic receptor-mediated G i protein/phosphatidylinositol 3-kinase/Akt signaling and voltage-activated Ca 2ϩ influx for stimulation of calmodulindependent endothelial NO synthase activity. Increases in NO i elicited by ACh withdrawal result from the recovery of Ca 2ϩ influx after ACh inhibition. NO signaling elicited by ACh withdrawal stimulates rapid recovery from cholinergic atrial inhibition. (Circ Res. 2003;93:1233-1240.) Key Words: phosphatidylinositol 3-kinase Ⅲ protein kinase B/Akt Ⅲ calmodulin Ⅲ calcium Original
S everal studies indicate that NO signaling mediates the inhibitory effects of acetylcholine (ACh) on cardiac function. [1] [2] [3] These findings, however, have been disputed 4 -6 and remain controversial. 7 In cat atrial myocytes, AChinduced inhibition of basal L-type Ca 2ϩ current (I Ca,L ) is not mediated by NO signaling. 8 However, ACh withdrawal stimulates I Ca,L above control levels, ie, rebound stimulation, and this response is mediated by NO signaling. 8, 9 The rebound stimulation of I Ca,L elicited by ACh withdrawal results in stimulation of atrial contraction, 9 atrial pacemaker activity, 10 and the potential development of Ca 2ϩ -mediated delayed afterdepolarizations and arrhythmic atrial activity. 11 These findings are consistent with reports in multicellular atrial preparations that ACh withdrawal elicits rebound stimulation of intracellular Ca 2ϩ transients and contraction. 12 The fact that rebound stimulation is exhibited by multicellular tissue indicates that the stimulatory response to ACh withdrawal is not unique to isolated myocytes but rather is a physiological mechanism responsible for rapid recovery from cholinergic inhibition of atrial function. In both cat 8 and human 13 atrial myocytes, NO acts via cyclic GMP (cGMP)-induced inhibition of phosphodiesterase type III activity to increase endogenous cAMP levels. By this mechanism, NO signaling mediates the stimulation of I Ca,L elicited by ACh withdrawal. 8 These findings are consistent with studies in chick heart cells, in which ACh withdrawal stimulates cAMP above control levels. 14 Others laboratories have reported that ACh withdrawal stimulates I Ca,L in Purkinje fibers 15 and ventricular myocytes prestimulated by ␤-adrenergic agonists. 16, 17 However, in contrast to atrial myocytes, the stimulatory effect of ACh withdrawal in ventricular myocytes is not mediated via NO or cGMP signaling 16, 18 but rather is attributable to stimulation of adenylate cyclase by the ␤␥ subunit of G i protein. 16 In the present study, we used fluorescence microscopy and the NO-sensitive indicator DAF-2 to directly determine the effects of ACh on intracellular NO (NO i ) production in cat atrial myocytes. We also sought to determine whether stim-ulation of muscarinic receptors increases NO i production via G i proteins coupled to phosphatidylinositol 3-kinase (PI-3K)/ protein kinase B (Akt) signaling, similar to NO i production elicited by ␤ 2 -adrenergic receptor (AR) stimulation. 19 The present results indicate that ACh exposure and withdrawal increase NO i production. ACh-induced increases in NO i require both muscarinic receptor-mediated G i /PI-3K/Akt signaling and voltage-activated Ca 2ϩ influx for stimulation of calmodulin (CaM)-dependent endothelial NO synthase (eNOS) activity. Moreover, ACh withdrawal increases NO i production above that induced during ACh exposure, consistent with the role of NO signaling in rebound stimulation of I Ca,L .
Materials and Methods
Adult cats of either sex were anesthetized with sodium pentobarbital (50 mg/kg IP). Once anesthetized, the heart was rapidly excised and mounted on a Langendorff perfusion apparatus. Atrial myocytes were dispersed by enzymatic (collagenase; type II, Worthington Biochemical) digestion, as previously reported. 20 Measurements of NO i were obtained by incubating cells with the fluorescent NOsensitive dye 4,5-diaminofluorescein (DAF-2), 21, 22 as previously described 19, 23 (for additional details, see the online data supplement, available at http://www.circresaha.org). Experiments were performed at room temperature. Changes in cellular DAF-2 fluorescence intensities (F) were normalized to the level of fluorescence recorded before stimulation (F 0 ), and changes in [NO] i are expressed as F/F 0 . Activation of DAF-2 by NO is irreversible, and therefore fluorescence intensity remains constant even if NO i levels decrease. In a few experiments, perforated patch recording methods were used to measure electrical activity of atrial myocytes, as previously described. 11 Two-dimensional (2D) and fast one-dimensional (linescan) imaging was performed using a confocal scanning unit (LSM 410, Zeiss) attached to an inverted microscope (Axiovert 100, Zeiss) fitted with a 40 oil-immersion objective lens (Plan-Neofluar, numerical aper-tureϭ1.3, Zeiss). Atrial myocytes were loaded with the NO-sensitive indicator DAF-2, as described above. DAF-2 fluorescence was excited with a 488-nm line of an argon ion laser, and emitted fluorescence was collected at wavelength Ͼ515 nm. For linescan imaging, the specimen was scanned repetitively at 5-ms intervals. All linescan images were recorded at a central focal plane and oriented along the longitudinal axis of the cell within the subsarcolemmal region. Increases in NO i recorded by linescan were quantified by measuring the frequency and amplitude of NO i peaks. NO i peaks were defined as those changes in NO i that reached 50% above baseline (F/F 0 ).
Immunoblots were used to analyze ACh-induced phosphorylation of Akt (protein kinase B). Isolated atrial cells were treated with control media (M199), 10 mol/L ACh, ACh plus 10 mol/L LY294002, low (0.5 mmol/L) [Ca 2ϩ ] o , or ACh plus 0.5 mmol/L [Ca 2ϩ ] o before harvesting. Cells were incubated with LY294002 for 10 minutes, followed by a 2-minute exposure to ACh (for additional details, see the online data supplement).
Drugs in this study included acetylcholine chloride, atropine, LY294002, L-N 5 -(1-iminoethyl)ornithine (L-NIO), N-(6aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7), verapamil, methyl-␤-cyclodextrin, pertussis toxin (all from Sigma Chemical), and 4,5-diaminofluorescein diacetate (DAF-2 DA) (Calbiochem). NO i measurements obtained from two groups of cells were analyzed using Student's unpaired t test for significance at PϽ0.05. Multiple groups were analyzed using ANOVA followed by Student Newman-Keuls test for significance at PϽ0.05.
An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org. Figure 1A shows a typical recording of NO i production obtained from a field-stimulated (ϩFS, 1 Hz) atrial myocyte and a second quiescent (ϪFS) atrial myocyte exposed to 1 mol/L ACh. In the field-stimulated cell, ACh exposure elicited an increase in NO i , and withdrawal of ACh elicited an additional, prominent increase in NO i above that elicited during ACh exposure (nϭ16). In the quiescent cell (ϪFS), ACh exposure and withdrawal had no effect on NO i (nϭ6). However, in the same cell exposure to the NO donor, spermine/NO (Sper/NO; 100 mol/L) prominently increased NO i ( Figure 1A) . The response to Sper/NO indicates that the DAF-2 indicator was functioning normally and thereby serves as a positive control. Field stimulation alone also had no effect on NO i production (data not shown; nϭ12). Previous work showed that termination of ACh action by atropine elicits rebound stimulation of I Ca,L typically obtained by ACh withdrawal. 9 In the present study, after Ϸ3 minutes of ACh exposure, addition of 1 mol/L atropine elicited an increase in NO i production similar to that elicited by ACh withdrawal (data not shown; nϭ3). The effects of ACh exposure and withdrawal on NO i production are summarized in Figure 1D and indicate that ACh exposure elicits a relatively modest increase in NO i production and that ACh withdrawal elicits additional, prominent increases in NO i above those elicited during ACh exposure. Moreover, the receptor-mediated effects of ACh to increase NO i require electrical stimulation of the cell, presumably to increase Ca 2ϩ influx (see below). Therefore, all additional experiments were performed on myocytes field-stimulated at 1 Hz. Figure 1B shows the effects of ACh recorded from another atrial myocyte in the presence of 10 mol/L L-NIO, a specific inhibitor of eNOS activity. 24 As summarized in Figure 1D , compared with control responses, inhibition of eNOS essentially abolished the effects of ACh exposure and withdrawal to increase NO i (nϭ10). In the same cell, 100 mol/L Sper/NO prominently increased NO i . In cardiac cells, eNOS is localized to caveolae. 25 Methyl-␤-cyclodextrin (cyclodextrin) solubilizes cholesterol and thereby disrupts caveolae formation. 26 ACh was tested on atrial myocytes incubated (1 hour at 37°C) in 2 mmol/L cyclodextrin. As shown in Figure 1C and summarized in Figure 1D , cyclodextrin abolished the increases in NO i induced by ACh exposure and withdrawal (nϭ3). Together, these findings indicate that ACh increases NO i by stimulating eNOS activity localized to caveolae.
Results
The fact that ACh-induced increases in NO i require that cells be electrically stimulated suggests that voltage-activated Ca 2ϩ influx is an essential signaling element, consistent with the Ca 2ϩ -CaM dependence of eNOS activity. We therefore tested the effects of ACh to increase NO i when the extracellular Ca 2ϩ concentration ([Ca 2ϩ ] o ) was reduced to either 1 or 0.5 mmol/L before ACh exposure. As shown in Figure 2A and summarized in Figure 2D , compared with control (2 mmol/L), reducing [Ca 2ϩ ] o to 1 mmol/L decreased NO i production elicited during ACh exposure and withdrawal (nϭ10), and 0.5 mmol/L [Ca 2ϩ ] o essentially abolished the increase in NO i elicited during ACh exposure and withdrawal (nϭ5). Similar results were obtained by exposure to 1 mol/L verapamil, an L-type Ca 2ϩ channel antagonist (data not shown; nϭ3). In separate experiments, bathing cells in 0.5 mmol/L [Ca 2ϩ ] o or verapamil did not prevent electrical excitation elicited by field stimulation (nϭ3). To determine the role of CaM, ACh was tested on atrial myocytes pretreated with 10 mol/L W-7, a potent CaM inhibitor. 27 As shown in Figure 2B and summarized in Figure 2D , compared with control, W-7 abolished increases in NO i induced by ACh exposure and withdrawal (nϭ5). In the same cell, 100 mol/L Sper/NO prominently increased NO i . To determine whether Ca 2ϩ influx specifically contributes to the additional increase in NO i elicited by ACh withdrawal, we switched to 0.5 mmol/L [Ca 2ϩ ] o specifically during ACh withdrawal. As shown in Figure 2C and summarized in Figure 2D , ACh exposure in normal (2 mmol/L) [Ca 2ϩ ] o elicited a typical increase in NO i . However, ACh withdrawal in low [Ca 2ϩ ] o failed to significantly increase NO i above that elicited by ACh exposure (nϭ4). In the four cells tested, NO i levels during ACh exposure in normal [Ca 2ϩ ] o (1.041Ϯ0.009 F/F 0 ) and during ACh withdrawal in 0.5 mmol/L [Ca 2ϩ ] o (1.053Ϯ0.011 F/F 0 ) were not different. As summarized in Figure 2D , NO i during ACh withdrawal was significantly smaller in 0.5 mmol/L [Ca 2ϩ ] o (hatched bar) compared with control ACh withdrawal (black bar). These findings indicate that the ability of ACh exposure and withdrawal to increase NO i depends on Ca 2ϩ influx, presumably to activate CaMdependent eNOS.
Previous findings in cat atrial myocytes indicate that the effect of ACh withdrawal to stimulate I Ca,L is mediated via muscarinic receptors coupled to G i protein signaling. 9 Moreover, ␤ 2 -AR stimulation acts via G i protein and PI-3K signaling to increase NO i . 19 We therefore sought to determine whether muscarinic receptors act via a similar G i protein/ PI-3K signaling pathway to increase NO i . As shown in Figure 3A, compared with control responses, pretreatment with the muscarinic receptor antagonist (1 mol/L) atropine blocked NO i production induced by ACh exposure and withdrawal (nϭ6). In Figure 3B , incubating cells in pertussis toxin (PTX) (3.5 g/mL; 3 hours, 36°C) to inhibit G i protein signaling also abolished increases in NO i induced by ACh exposure and withdrawal (nϭ6). In the same PTX-treated cell ( Figure 3B ), 100 mol/L Sper/NO prominently increased NO i . To examine the role of PI-3K signaling, cells were incubated in 10 mol/L LY294002, an inhibitor of PI-3K signaling, 28 for 30 minutes before being tested with ACh. Previous work has shown that either LY294002 or wortmannin, another inhibitor of PI-3K signaling, inhibits ␤ 2 -AR stimulation of NO i release. 19 As shown in Figure 3C , inhibition of PI-3K signaling by LY294002 also inhibited NO i production elicited by ACh exposure and withdrawal (nϭ7). Once again, in the same cell treated with LY294002, 100 mol/L Sper/NO prominently increased NO i . The results are summarized in the graph in Figure 3D and indicate that ACh acts on muscarinic receptors coupled via G i proteins and PI-3K signaling to stimulate NO i production. Apparently, muscarinic and ␤ 2 -ARs act via the same G i protein/PI-3K signaling pathway to stimulate NO i production.
In endothelial cells, PI-3K signaling phosphorylates protein kinase B (Akt), which in turn activates eNOS. 29, 30 We therefore used immunoblots to determine the effects of ACh on Akt phosphorylation. As shown in Figure 4 , compared with control, 10 mol/L ACh significantly increased phos- phorylation of Akt. Pretreatment with 10 mol/L LY294002 prevented ACh-induced phosphorylation of Akt (nϭ5). These results are consistent with the present findings that inhibition of PI-3K signaling (LY294002) inhibits ACh-induced NO i production ( Figure 3C ). It is also important to note that in the experiments designed to measure Akt phosphorylation, cells were quiescent. That is, under these conditions, voltage-activated Ca 2ϩ influx is not operating and therefore the cells are not capable of ACh-induced NO i production (see Figure 1A ). This indicates that ACh-induced stimulation of PI-3K/Akt signaling occurs independently of voltage-activated Ca 2ϩ influx and is not capable per se of stimulating NO i production. To gain additional insight into the Ca 2ϩ dependence of ACh-induced phosphorylation of Akt, we tested the effects of ACh in control (2 mmol/L) and low (0.5 mmol/L) [Ca 2ϩ ] o (see online Figure 2 , available at http://www.circresaha.org). The results of these experiments show that in low [Ca 2ϩ ] o , ACh still increased Akt phosphorylation. We therefore conclude that although Ca 2ϩ is necessary for ACh-induced NO i production, presumably to activate CaM-dependent eNOS, AChinduced activation of Akt signaling is Ca 2ϩ -independent.
We next used high-resolution confocal imaging to examine spatial patterns of NO i release induced by ACh exposure and withdrawal. Figure 5A shows typical 2D surface plots of atrial cells during control, ACh exposure, and ACh withdrawal. Compared with control, ACh exposure increased NO i at local sites along the cell periphery. ACh withdrawal elicited additional increases in NO i , primarily by recruiting additional release sites along the cell periphery. Figure 5B shows that in another atrial myocyte pretreated (1 hour) with 2 mmol/L methyl-␤-cyclodextrin, ACh failed to elicit any changes in NO i either during ACh exposure or withdrawal. Similar results were obtained in a total of four cells.
Spatial changes in ACh-induced NO i production were examined in more detail by recording NO i using a repetitively scanned line positioned parallel with the longitudinal axis of the cell within the subsarcolemmal region. The graph in Figure 5C shows spatial profiles of local changes in NO i average over time and expressed as F/F 0 during ACh exposure (red trace) and ACh withdrawal (blue trace). ACh exposure increased NO i at local subsarcolemmal sites and elicited small increases in baseline NO i . ACh withdrawal Baseline NO i levels also were increased additionally. D, Graph summarizes the increases in NO i elicited by ACh exposure (red bars) and ACh withdrawal (blue bars) by quantifying the amplitude and frequency of NO i release events recorded by linescan (nϭ5). NO i peaks were defined as those changes in NO i that reached 50% above baseline (dashed line). Frequency of NO i peaks were normalized to scanned cell length (peaks/ m). Cells were electrically field-stimulated at 1 Hz. *PϽ0.05. elicited additional increases in NO i by enhancing NO i release at some sites previously stimulated during ACh exposure (for example, site 1) and by recruiting additional subsarcolemmal release sites (for example, sites 2, 3, and 4). Also, baseline NO i levels were increased additionally. Incubation of cells in 2 mmol/L cyclodextrin abolished all effects of ACh to increase NO i (data not shown). Similar results were obtained in a total of five cells. The graph in Figure 5D summarizes the increases in amplitude (in relation to baseline) and frequency of NO i release events elicited by ACh exposure (red bars) and ACh withdrawal (blue bars) (nϭ5). ACh exposure increased both the amplitude and frequency of NO i release events, and these parameters were significantly greater during ACh withdrawal compared with ACh exposure.
Discussion
Previous studies from our laboratory have shown that in cat atrial myocytes, ACh exposure inhibits I Ca,L and ACh withdrawal stimulates I Ca,L above control levels, ie, rebound stimulation. 9 Pharmacological analyses indicated that although NO signaling does not participate in ACh-induced inhibition of I Ca,L , the rebound stimulation of I Ca,L elicited by ACh withdrawal is mediated by NO signaling. 8 The present study directly demonstrates for the first time that in atrial myocytes, ACh exposure increases NO i production and ACh withdrawal elicits an additional, prominent increase in NO i above that achieved during ACh exposure. The actions of ACh require both stimulation of muscarinic receptor-mediated G i protein/PI-3K/Akt signaling and voltage-activated Ca 2ϩ influx to elicit local, subsarcolemmal increases in NO i production.
The present results indicate that muscarinic receptor stimulation by ACh is unable to stimulate NO i production in quiescent atrial myocytes. ␤ 2 -AR stimulation also requires electrical stimulation of atrial myocytes to increase NO i production. 19 Given the Ca 2ϩ -CaM dependence of eNOS activity, these findings suggest that voltage-activated Ca 2ϩ influx is essential for receptor-mediated stimulation of NO i . Indeed, in electrically stimulated atrial myocytes, AChinduced increases in NO i are decreased (1 mmol/L) or abolished (0.5 mmol/L) by reducing [Ca 2ϩ ] o , inhibition of L-type Ca 2ϩ channels (verapamil), or inhibition of CaM activity (W-7). In addition, lowering [Ca 2ϩ ] o specifically during ACh withdrawal prevented the additional, prominent increase in NO i . In endothelial cells, removal of extracellular Ca 2ϩ 31 or exposure to CaM antagonists 32 also abolishes agonist-induced NO formation. Although electrical stimulation is required for receptor-mediated NO i production, it is not sufficient per se to elicit NO i production. In other words, in atrial myocytes, basal voltage-activated Ca 2ϩ influx and presumably intracellular Ca 2ϩ release induced by Ca 2ϩ influx are not capable of stimulating eNOS activity. This is in contrast to findings in rat ventricular myocytes in which basal Ca 2ϩ influx elicited by electrical stimulation is sufficient to increase nitrite levels. 33 We have obtained similar results in cat ventricular myocytes, where electrical stimulation alone is sufficient to increase NO i production (unpublished observations). In electrically stimulated atrial myocytes, even marked increases in Ca 2ϩ influx via I Ca,L and presumably intracellular Ca 2ϩ release induced by ␤ 1 -AR stimulation fail to increase NO i . 19 On the other hand, ␤ 2 -AR stimulation elicits a similar increase in I Ca,L and does increase NO i . 19 Together, these findings indicate that, in atrial myocytes, voltage-activated Ca 2ϩ influx and intracellular Ca 2ϩ release per se are not sufficient to stimulate NO i production. However, Ca 2ϩ influx is essential for NO i production stimulated by specific receptor-mediated signaling. The contribution of intracellular Ca 2ϩ release to muscarinic receptor-mediated NO i production remains to be determined.
In the present study, ACh acts via muscarinic receptors coupled to G i proteins and PI-3K/Akt signaling to activate CaM-dependent NO i production. Our previous studies have shown that in cat atrial myocytes, stimulation of I Ca,L elicited by ACh withdrawal also is mediated via muscarinic receptors coupled to G i proteins and activation of CaM-dependent NO signaling. 8 In a variety of cell systems, PI-3K signaling leads to phosphorylation and activation of Akt signaling. 34 In both endothelial 29, 30 and cardiac 35 cells, PI-3K/Akt signaling phosphorylates and activates eNOS to produce NO. The present experiments indicate that ACh is not capable of eliciting NO i production in quiescent atrial cells because of the requirement for voltage-activated Ca 2ϩ influx. However, the immunoblot experiments show that ACh is able to stimulate PI-3K/Akt signaling in quiescent cells ( Figure 4A ). These findings suggest that muscarinic receptor-mediated stimulation of PI-3K/Akt signaling is not capable per se of stimulating NO i production and that stimulation of this signaling pathway occurs independently of voltage-activated Ca 2ϩ influx. The latter finding is supported by the fact that lowering [Ca 2ϩ ] o to a level (0.5 mmol/L) that prevents ACh-induced NO i production failed to prevent ACh-induced Akt phosphorylation (see online Figure 2 ). This is consistent with reports that Akt activation is Ca 2ϩ -independent. 36 We therefore conclude that receptor-mediated PI-3K/Akt signaling plus voltage-activated Ca 2ϩ influx are both required for stimulation of NO i production. Our previous experiments indicate that in cat atrial myocytes, ␤ 2 -AR stimulation also requires both PI-3K signaling and voltage-activated Ca 2ϩ influx to elicit NO i production. 19 This dual signaling mechanism can account for the relatively small NO i production elicited during ACh exposure and the more prominent increase in NO i elicited by ACh withdrawal. Thus, ACh exposure stimulates PI-3K/Akt signaling at the same time that it decreases Ca 2ϩ influx via I Ca,L , thereby allowing only a modest increase in NO i production. However, once PI-3K/Akt signaling is stimulated by ACh exposure, rapid removal of ACh from its receptor allows rapid recovery of Ca 2ϩ influx, resulting in the additional, prominent stimulation of NO i production. Moreover, because ACh withdrawal results in the recovery of adenylate cyclase/ cAMP signaling, increases in NO i stimulate cAMP-mediated increases in Ca 2ϩ influx via I Ca,L , 8 which in turn contribute to additional Ca 2ϩ -dependent increases in NO i . Our interpretation that NO i production is modulated by Ca 2ϩ influx is supported by experiments in which we recorded intracellular [Ca 2ϩ ] and NO i simultaneously (see online Figure 1 ). In endothelial cells, receptor-mediated signaling by bradykinin can act independently of PI-3K/Akt signaling to enhance the binding of CaM to eNOS and thereby enhance the Ca 2ϩ sensitivity of eNOS activity. 37 This mechanism results in high-output Ca 2ϩ -dependent NO production. It seems unlikely, however, that a similar mechanism plays a primary role in atrial myocytes given the present finding that AChinduced increases in NO i are entirely dependent on PI-3K/Akt signaling.
The contribution of NO signaling to muscarinic receptormediated inhibition of cardiac function differs among different species, tissues, and reports from different laboratories. 7 Although the present results show that ACh exposure modestly increases NO i production, NO signaling does not contribute to ACh-induced inhibition of I Ca,L . 8 In fact, in cat atrial myocytes, NO signaling stimulates I Ca,L via cAMP-dependent protein kinase A signaling 8 and therefore would not be expected to contribute to the inhibitory effects of ACh. Moreover, the fact that ACh inhibits basal adenylate cyclase/ cAMP activity would preclude any significant effects of NO signaling on cAMP-mediated regulation of I Ca,L . In addition, the level of NO i production during ACh exposure may be below the threshold required for activation of cGMPmediated signaling and modulation of channel function.
The present results indicate that ACh increases NO i primarily at the cell periphery and disruption of caveolae formation by cyclodextrin abolishes ACh-induced increases in NO i . These findings are consistent with reports that in cardiac cells eNOS is localized to caveolae through binding to the scaffolding protein caveolin-3. 25, 38 The binding of caveolin holds eNOS in an inactive conformation. 38, 39 Increases in Ca 2ϩ concentration activate CaM binding to eNOS, thereby disrupting the inhibitory eNOS-caveolin complex and activating eNOS activity. 39 M 2 muscarinic receptors are thought to translocate to caveolae once stimulated by agonist. 40 Moreover, stimulation of M 2 muscarinic receptors causes a reversible translocation of eNOS from caveolae and may partition the enzyme into both noncaveolar plasma membrane and more hydrophilic regions of the cell. 41 Because cat atrial myocytes lack T-tubules, 42 the peripheral sarcolemmal membrane is the only site of voltage-activated Ca 2ϩ influx and the region most abundant in caveolae. The finding that ACh withdrawal stimulates additional NO i release sites suggests that different release sites exhibit different thresholds for stimulation of NO i production. The preferential release of NO i from subsarcolemmal sites also is consistent with the local regulation of sarcolemmal channel function exerted by NO i signaling. 19, 43 Clearly, the prominent increase in NO i elicited by ACh withdrawal strongly supports our previous findings that rebound stimulation of I Ca,L elicited by ACh withdrawal is mediated by NO signaling. 8 In vivo, the actions of ACh at the muscarinic receptor are terminated almost instantaneously by cholinesterase activity. We therefore propose that the NO signaling mechanisms reported here play an important role in ensuring rapid recovery of both chronotropic 10 and inotropic 9 activities after cholinergic inhibition of atrial function. In fact, we have reported that NO i signaling elicited by ACh withdrawal may contribute to the nonadrenergic component of postvagal tachycardia 10 and the potential development of Ca 2ϩ -mediated atrial dysrhythmias 11 induced by withdrawal of parasympathetic nerve activity. 44 
